参考文献/References:
[1] F?GER-SAMWALD U,KERSCHAN-SCHINDL K,BUTYLINA M,et al.Age related osteoporosis:targeting cellular senescence[J].Int J Mol Sci,2022,23(5):2701.
[2] BDIL A E,RDULESCU D M,ILIE A,et al.Bone regeneration and oxidative stress:an updated overview[J].Antioxidants(Basel),2022,11(2):318.
[3] DING P,TAN Q,WEI Z,et al.Toll-like receptor 9 deficiency induces osteoclastic bone loss via gut microbiota-associated systemic chronic inflammation[J].Bone Res,2022,10(1):42.
[4] YANG Y,WANG Y J,WANG F,et al.The roles of miRNA,lncRNA and circRNA in the development of osteoporo-sis[J].Biol Res,2020,53(1):40.
[5] ANTHAMATTEN A,PARISH A.Clinical update on osteoporosis[J].J Midwifery Womens Health,2019,64(3):265-275.
[6] YU B,WANG C Y.Osteoporosis and periodontal diseases—an update on their association and mechanistic links[J].Periodontol 2000,2022,89(1):99-113.
[7] 张浩龙,赵瑞,潘静,等.巨噬细胞极化在骨质疏松症中的研究进展[J].中国骨质疏松杂志,2024,30(3):418-423.
[8] 靳博,章晓云,李勇进.成骨细胞铁死亡与Nrf2-ARE的相互作用在骨质疏松防治领域的研究进展[J].海南医科大学学报,2025,31(2):152-160.
[9] 魏秀容,杨子江,张秀娟.巨噬细胞极化及其在临床疾病治疗中的潜在应用价值[J].生理科学进展,2024,55(4):296-303.
[10] YANG D,WAN Y.Molecular determinants for the polarization of macrophage and osteoclast[J].Semin Immunopathol,2019,41(5):551-563.
[11] DOU C,DING N,ZHAO C,et al.Estrogen deficiency-mediated M2 macrophage osteoclastogenesis contributes to M1/M2 ratio alteration in ovariectomized osteoporotic mice[J].J Bone Miner Res,2018,33(5):899-908.
[12] 李沐哲,牛园园,张天驰,等.温肾通络止痛方通过SENP1-SIRT3通路调控巨噬细胞极化改善骨髓间充质干细胞成骨分化和去睾丸小鼠的骨丢失[J].中华中医药杂志,2024,39(9):4619-4626.
[13] ZHAO K,TUFAIL S,ARAI Y,et al.Effect of phytic acid and morphology on Fe(oxyhydr)oxide transport under saturated flow condition[J].J Hazard Mater,2022,424(Pt D):127659.
[14] BERNDT C,LILLIG C H.Glutathione,glutaredoxins,and Iron[J].Antioxid Redox Signal,2017,27(15):1235-1251.
[15] SCHULZ V,BASU S,FREIBERT S A,et al.Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2[J].Nat Chem Biol,2023,19(2):206-217.
[16] XIE Y,KANG R,KLIONSKY D J,et al.GPX4 in cell death,autophagy,and disease[J].Autophagy,2023,19(10):2621-2638.
[17] YANG W,WANG Y,ZHANG C,et al.Maresin1 protect against ferroptosis-induced liver injury through ROS inhibition and Nrf2/HO-1/GPX4 activation[J].Front Pharmacol,2022,13:865689.
[18] MU?OZ M,ROBINSON K,SHIBLI-RAHHAL A.Bone health and osteoporosis prevention and treatment[J].Clin Obstet Gynecol,2020,63(4):770-787.
[19] YANG Y,LIN Y,WANG M,et al.Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis[J].Bone Res,2022,10(1):26.
[20] 徐巧.白藜芦醇通过激活Nrf2/HO-1信号通路抑制地塞米松诱导的成骨细胞铁死亡[D].沈阳:中国医科大学,2024.
[21] CAI H,LI Z,DIKALOV S,et al.NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensinⅡ[J].J Biol Chem,2002,277(50):48311-48317.
[22] HANDA P,THOMAS S,MORGAN-STEVENSON V,et al.Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis[J].J Leukoc Biol,2019,105(5):1015-1026.
[23] 陆嘉佳.TNF-α通过上调骨髓造血干细胞嘌呤受体促进其分化并加剧绝经后骨质疏松症的机制研究[D].上海:海军军医大学,2020.
[24] LI W,XU P,WANG C,et al.The effects of fat-induced obesity on bone metabolism in rats[J].Obes Res Clin Pract,2017,11(4):454-463.
[25] 张彦军,刘晏东,邓强,等.铁死亡对椎间盘变性的影响机制研究进展[J].中国细胞生物学学报,2024,46(5):1075-1081.
[26] YAPICI F I,BEBBER C M,VON KARSTEDT S.A guide to ferroptosis in cancer[J].Mol Oncol,2024,18(6):1378-1396.
[27] CHEN X,LIU C,YU R,et al.Interaction between ferroptosis and TNF-α:impact in obesity-related osteoporosis[J].FASEB J,2023,37(6):e22947.
[28] 李帅帅,罗瑞熙,韦亚琼,等.黄芩苷通过调控TLR4/NF-κB信号通路对脂多糖诱导RAW264.7细胞极化的影响[J].中成药,2022,44(12):3835-3841.
[29] 龙隆海.黄芩苷通过巨噬细胞M2极化促进骨髓间充质干细胞成骨分化的机制研究[D].泸州:西南医科大学,2024.
[30] LI M,NIU Y,TIAN L,et al.AstragalosideⅣalleviates macrophage senescence and d-galactose-induced bone loss in mice through STING/NF-κB pathway[J].Int Immunopharmacol,2024,129:111588.
[31] LI J,SUN K,QI B,et al.An evaluation of the effects and safety of Zuogui pill for treating osteoporosis:current evidence for an ancient Chinese herbal formula[J].Phytother Res,2021,35(4):1754-1767.
[32] SHEN C,DENG M,WANG X,et al.Zuogui wan modulates macrophage polarization and promotes osteogenic differentiation through regulation of CD51-positive bone marrow me-senchymal stem cells[J].Sci Rep,2024,14(1):26130.
[33] 毛佳乐,林炳锋,张晓芹,等.基于VDR/GPX4通路探讨小檗碱对去卵巢小鼠骨丢失的抑制作用[J].中国中医药科技,2024,31(6):983-988.
[34] 陈涛,余良昆,陈瑶,等.葛根素调控SLC7A11/GPX4轴抑制高糖诱导的成骨细胞铁死亡[J].中国骨质疏松杂志,2023,29(12):1805-1812.
[35] 张京京,杜红岩,李钦,等.杜仲药理与毒理研究进展[J].河南大学学报(医学版),2014,33(3):217-222.
[36] HAO J,BEI J,LI Z,et al.Qing'e pill inhibits osteoblast ferroptosis via ATM serine/threonine kinase(ATM)and the PI3K/AKT pathway in primary osteoporosis[J].Front Pharmacol,2022,13:902102.
[37] 章轶立,方圣杰,李秋月,等.补骨生髓方对骨质疏松症模型大鼠氧化应激及铁死亡相关指标的影响[J].中国中医药信息杂志,2022,29(4):75-79.
[38] 郭浩然,刘亭,王立烨,等.铁抑素-1通过抑制肺上皮细胞铁死亡减轻高原低氧肺损伤炎症反应[J].陆军军医大学学报,2025,47(12):1261-1275.
[39] XU W,LV S,WANG X,et al.Ferrostatin-1 inhibits osteoclast differentiation and prevents osteoporosis by suppressing lipid peroxidation[J].J Orthop Surg Res,2025,20(1):117.
[40] 王铜浩,田永刚,韩立强,等.姜黄素对骨质疏松鼠模型作用机制的研究[J].医学信息,2022,35(8):30-33.
[41] 李明.基于铁死亡p53/SLC7A11/GPX4通路探究姜黄素抑制破骨细胞分化的机制[D].恩施:湖北民族大学,2025.
[42] OGRODNIK M.Cellular aging beyond cellular senescence:markers of senescence prior to cell cycle arrest in vitro and in vivo[J].Aging Cell,2021,20(4):e13338.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(11):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(11):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(11):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(11):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(11):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(11):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(11):16.